Glatopa (glatiramer acetate injection) 20mg/mL is the first FDA-approved, substitutable generic for Copaxone® (glatiramer acetate injection) 20mg/mL for the treatment of patients with relapsing-forms of multiple sclerosis.1-4

Therapeutic Equivalence

HCP banner 1

Glatopa 20mg/mL is FDA approved as an AP-rated, substitutable generic that is therapeutically equivalent to Copaxone® 20mg/mL1-5:

  • Contains the same active ingredient
  • Same indication
  • Is identical in strength, dosage and route of administration
  • Meets the same requirements for performance, strength, purity and quality
  • Demonstrates no observable differences in physiochemical, biological or immunological properties

HCP banner 2

*Glatopa 20 mg/mL dose is not interchangeable with glatiramer acetate 40 mg/mL dose.
Demonstrated equivalence to Copaxone® 20mg/mL.1,2

Glatopa is therapeutically equivalent to Copaxone® 20mg/mL, with comprehensive FREE patient support services from Sandoz, a Novartis Division.

Please see full Prescribing Information for Glatopa.

 

Related content

Enroll Now

Enroll Now

Encourage your patients to Enroll  in GlatopaCare® for individualized patient support services. 1.855.GLATOPA (1.855.452.8672).